Camp4 Therapeutics Corporation · NASDAQ:CAMP
Schwab Andrew J. sold 400,000 Camp4 Therapeutics Corporation shares (Form 4)
Traded Aug 27, 2026 · Filed Aug 31, 2026
On Aug 27, 2026, Schwab Andrew J. (Director) sold 400,000 Camp4 Therapeutics Corporation shares at US$4.04 for US$1.62M, leaving 2,033,270 shares. Filed Aug 31, 2026 (Form 4).
- Sold
- 400,000 shares
- Price
- US$4.04
- Value
- US$1.62M
- Holding after
- 2,033,270 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Common Stock | Sale | 400,000 | US$4.04 | 2,033,270 | Indirect |
Source
Related
- Camp4 Therapeutics Corporation
- Schwab Andrew J.
- Camp4 Therapeutics Corporation shareholders
- Form 4 · Schwab Andrew J. · Aug 26, 2026
- Form 4 · Schwab Andrew J. · Aug 21, 2026
- Form 4 · Gold Kelly · Sep 2, 2026
- Schedule 13D/A · Schwab Andrew J. · Aug 31, 2026
- Form 4 · Tardiff Daniel · Aug 19, 2026
- Schedule 13D/A · Amir Nashat · Aug 19, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026